# Migratory vasodilatation of cerebral arteries in MELAS episodes: a case report and literature review

**Authors:** Ying Luo, Quanhong Chu, Taochun Yu, Xiaoqing Lu, Yanmei Wang, Jie Li, Lingfeng Wu, Yaoyao Shen

PMC · DOI: 10.3389/fimmu.2026.1706012 · Frontiers in Immunology · 2026-02-05

## TL;DR

This case report and literature review explores migratory vasodilatation in cerebral arteries during MELAS episodes and its potential as a diagnostic imaging sign.

## Contribution

The study highlights migratory vasodilatation of cerebral arteries as a possible specific imaging feature of MELAS.

## Key findings

- Migratory vasodilatation of cerebral arteries was observed during stroke-like episodes in MELAS.
- Vasodilatation predominantly occurred in the posterior and middle cerebral arteries during acute phases.
- Increased cerebral blood flow corresponded to the vascular supply of the dilated arteries.

## Abstract

Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is the commonest inherited mitochondrial disorder. Dilation of the major cerebral arteries is seldom mentioned in MELAS because magnetic resonance angiography (MRA) usually shows normal findings. Here, we described a 24-year-old male patient with MELAS who had migratory vasodilatation of cerebral arteries on MRA and positive antibodies against contactin-associated protein-like-2 in serum during stroke-like episodes (SLEs). Moreover, a total of 18 MELAS cases were included in this literature review. MELAS with cerebrovascular dilatation was mainly seen in young adults and the commonest clinical manifestations were visual symptoms, headache, and seizures. Vasodilatation predominantly occurred in the acute phase of SLEs. Dilation of the major cerebral artery mainly happened in the posterior cerebral artery and the middle cerebral artery. The region of increased cerebral blood flow (CBF) always corresponded to the range of vascular supply of the dilated cerebral artery. Multimodal neuroimaging evaluation is very important for the diagnosis of mitochondrial diseases. Migratory vasodilation of cerebral arteries may be a specific imaging sign of MELAS. Dilation of cerebral artery together with increased CBF not only indicates the clinical onset, but also implies an upcoming stroke-like attack.

## Linked entities

- **Diseases:** MELAS (MONDO:0010789), lactic acidosis (MONDO:0006040)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TRNL1 (tRNA-Leu) [NCBI Gene 4567] {aka MTTL1}, CNTNAP2 (contactin associated protein 2) [NCBI Gene 26047] {aka AUTS15, CASPR2, CDFE, NRXN4, PTHSL1}
- **Diseases:** afferent (MESH:D000343), artery dilation or vasodilatation (MESH:D002311), encephalitis (MESH:D004660), cerebral infarction (MESH:D002544), occlusion (MESH:D001157), painful neuropathy (MESH:C564945), ataxia (MESH:D001259), impairment of blood (MESH:D006402), disturbance of consciousness (MESH:D003244), cortical blindness (MESH:D019575), deficiency (MESH:D007153), myoclonic or tonic-clonic (MESH:D004830), Mitochondrial encephalomyopathy with (MESH:D017237), lactic acidemia (MESH:D015325), HP (MESH:C537262), Epilepsy (MESH:D004827), hippocampal sclerosis (MESH:D000092223), limbic encephalitis (MESH:D020363), cognitive decline (MESH:D003072), memory impairment (MESH:D008569), visual field defect (MESH:D005128), viral encephalitis (MESH:D018792), MELAS (MESH:D017241), migraine (MESH:D008881), neuromyotonia (MESH:D020386), necrosis (MESH:D009336), MRI abnormalities (MESH:C564543), chronic hepatitis B. (MESH:D019694), myopathy (MESH:D009135), dementia (MESH:D003704), cortical lesions (MESH:D054220), blurred speech (MESH:D013064), infarction (MESH:D007238), depression (MESH:D003866), neck stiffness (MESH:D006258), hemianopsia (MESH:D006423), swelling (MESH:D004487), atrophy (MESH:D001284), anxiety (MESH:D001007), deafness (MESH:D003638), mental and behavior disturbance (MESH:D001523), diabetes (MESH:D003920), muscle weakness (MESH:D018908), cerebral ischemia (MESH:D002545), lactic acidosis (MESH:D000140), temporal lobe (MESH:D004833), tumor (MESH:D009369), AE (MESH:D020274), Visual symptoms (MESH:D014786), cortical necrosis (MESH:D007673), encephalomalacia (MESH:D004678), pupillary defect (MESH:D011681), short stature (MESH:D006130), inherited mitochondrial disorders (MESH:D028361), cerebral vascular impairment (MESH:D002532), mitochondrial cytopathy (MESH:C540770), headache (MESH:D006261), cerebral artery dilation (MESH:D002539), syphilis (MESH:D013587), Nonconvulsive status epilepticus (MESH:D013226)
- **Chemicals:** Riboflavin (MESH:D012256), L-arginine (MESH:D001120), fatty acid (MESH:D005227), proton (MESH:D011522), L-carnitine (MESH:D002331), 1H (-), prednisolone (MESH:D011239), glucose (MESH:D005947), coenzyme Q10 (MESH:C024989), lactate (MESH:D019344), oxygen (MESH:D010100), nitric oxide (MESH:D009569), chloride (MESH:D002712), oxcarbazepine (MESH:D000078330)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721]
- **Mutations:** A->G, 513 G > A, m.3243 A > G, m.1630 A > G, 3243A>G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916692/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916692/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916692/full.md

---
Source: https://tomesphere.com/paper/PMC12916692